Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies.

Hsu J, Santesso N, Mustafa R, Brozek J, Chen YL, Hopkins JP, Cheung A, Hovhannisyan G, Ivanova L, Flottorp SA, Saeterdal I, Wong AD, Tian J, Uyeki TM, Akl EA, Alonso-Coello P, Smaill F, Schünemann HJ.

Ann Intern Med. 2012 Apr 3;156(7):512-24. doi: 10.7326/0003-4819-156-7-201204030-00411. Epub 2012 Feb 27. Review.

PMID:
22371849
2.

Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses.

Nguyen JT, Smee DF, Barnard DL, Julander JG, Gross M, de Jong MD, Went GT.

PLoS One. 2012;7(1):e31006. doi: 10.1371/journal.pone.0031006. Epub 2012 Jan 23.

3.

Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis.

Osterholm MT, Kelley NS, Sommer A, Belongia EA.

Lancet Infect Dis. 2012 Jan;12(1):36-44. doi: 10.1016/S1473-3099(11)70295-X. Epub 2011 Oct 25. Review. Erratum in: Lancet Infect Dis. 2012 Sep;12(9):655.

PMID:
22032844
4.

Neuraminidase inhibitor susceptibility of swine influenza A viruses isolated in Germany between 1981 and 2008.

Bauer K, Dürrwald R, Schlegel M, Pfarr K, Topf D, Wiesener N, Dahse HM, Wutzler P, Schmidtke M.

Med Microbiol Immunol. 2012 Feb;201(1):61-72. doi: 10.1007/s00430-011-0206-1. Epub 2011 Jun 19.

PMID:
21688167
5.

A miniaturized assay for influenza neuraminidase-inhibiting antibodies utilizing reverse genetics-derived antigens.

Sandbulte MR, Gao J, Straight TM, Eichelberger MC.

Influenza Other Respir Viruses. 2009 Sep;3(5):233-40.

6.

Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (δ-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus.

Gauger PC, Vincent AL, Loving CL, Lager KM, Janke BH, Kehrli ME Jr, Roth JA.

Vaccine. 2011 Mar 24;29(15):2712-9. doi: 10.1016/j.vaccine.2011.01.082. Epub 2011 Feb 23.

PMID:
21310191
7.

Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro.

Gubareva LV, Trujillo AA, Okomo-Adhiambo M, Mishin VP, Deyde VM, Sleeman K, Nguyen HT, Sheu TG, Garten RJ, Shaw MW, Fry AM, Klimov AI.

Antivir Ther. 2010;15(8):1151-9. doi: 10.3851/IMP1678.

PMID:
21149922
8.

Swine influenza A vaccines, pandemic (H1N1) 2009 virus, and cross-reactivity.

Dürrwald R, Krumbholz A, Baumgarte S, Schlegel M, Vahlenkamp TW, Selbitz HJ, Wutzler P, Zell R.

Emerg Infect Dis. 2010 Jun;16(6):1029-30. doi: 10.3201/eid1606.100138. No abstract available.

9.

Replication, pathogenesis and transmission of pandemic (H1N1) 2009 virus in non-immune pigs.

Brookes SM, Núñez A, Choudhury B, Matrosovich M, Essen SC, Clifford D, Slomka MJ, Kuntz-Simon G, Garcon F, Nash B, Hanna A, Heegaard PM, Quéguiner S, Chiapponi C, Bublot M, Garcia JM, Gardner R, Foni E, Loeffen W, Larsen L, Van Reeth K, Banks J, Irvine RM, Brown IH.

PLoS One. 2010 Feb 5;5(2):e9068. doi: 10.1371/journal.pone.0009068.

10.

Serologic cross-reactivity with pandemic (H1N1) 2009 virus in pigs, Europe.

Kyriakis CS, Olsen CW, Carman S, Brown IH, Brookes SM, Doorsselaere JV, Reeth KV.

Emerg Infect Dis. 2010 Jan;16(1):96-9. doi: 10.3201/eid1601.091190.

11.

Genomic events underlying the changes in adamantane resistance among influenza A(H3N2) viruses during 2006-2008.

Deyde V, Garten R, Sheu T, Smith C, Myrick A, Barnes J, Xu X, Shaw M, Klimov A, Gubareva L.

Influenza Other Respir Viruses. 2009 Nov;3(6):297-314. doi: 10.1111/j.1750-2659.2009.00103.x.

12.

Preexisting immunity to pandemic (H1N1) 2009.

Xing Z, Cardona CJ.

Emerg Infect Dis. 2009 Nov;15(11):1847-9. doi: 10.3201/eid1511.090685. No abstract available.

13.

In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses.

Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, Muramoto Y, Tamura D, Sakai-Tagawa Y, Noda T, Sakabe S, Imai M, Hatta Y, Watanabe S, Li C, Yamada S, Fujii K, Murakami S, Imai H, Kakugawa S, Ito M, Takano R, Iwatsuki-Horimoto K, Shimojima M, Horimoto T, Goto H, Takahashi K, Makino A, Ishigaki H, Nakayama M, Okamatsu M, Takahashi K, Warshauer D, Shult PA, Saito R, Suzuki H, Furuta Y, Yamashita M, Mitamura K, Nakano K, Nakamura M, Brockman-Schneider R, Mitamura H, Yamazaki M, Sugaya N, Suresh M, Ozawa M, Neumann G, Gern J, Kida H, Ogasawara K, Kawaoka Y.

Nature. 2009 Aug 20;460(7258):1021-5. doi: 10.1038/nature08260.

14.

Pathogenesis and transmission of the novel swine-origin influenza virus A/H1N1 after experimental infection of pigs.

Lange E, Kalthoff D, Blohm U, Teifke JP, Breithaupt A, Maresch C, Starick E, Fereidouni S, Hoffmann B, Mettenleiter TC, Beer M, Vahlenkamp TW.

J Gen Virol. 2009 Sep;90(Pt 9):2119-23. doi: 10.1099/vir.0.014480-0. Epub 2009 Jul 10.

PMID:
19592456
15.

Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic.

Smith GJ, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, Pybus OG, Ma SK, Cheung CL, Raghwani J, Bhatt S, Peiris JS, Guan Y, Rambaut A.

Nature. 2009 Jun 25;459(7250):1122-5. doi: 10.1038/nature08182.

PMID:
19516283
16.

Genetic and antigenic evolution of swine influenza viruses in Europe and evaluation of their zoonotic potential.

Kuntz-Simon G, Madec F.

Zoonoses Public Health. 2009 Aug;56(6-7):310-25. doi: 10.1111/j.1863-2378.2009.01236.x. Review.

PMID:
19497089
17.

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans.

Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, Okomo-Adhiambo M, Gubareva L, Barnes J, Smith CB, Emery SL, Hillman MJ, Rivailler P, Smagala J, de Graaf M, Burke DF, Fouchier RA, Pappas C, Alpuche-Aranda CM, López-Gatell H, Olivera H, López I, Myers CA, Faix D, Blair PJ, Yu C, Keene KM, Dotson PD Jr, Boxrud D, Sambol AR, Abid SH, St George K, Bannerman T, Moore AL, Stringer DJ, Blevins P, Demmler-Harrison GJ, Ginsberg M, Kriner P, Waterman S, Smole S, Guevara HF, Belongia EA, Clark PA, Beatrice ST, Donis R, Katz J, Finelli L, Bridges CB, Shaw M, Jernigan DB, Uyeki TM, Smith DJ, Klimov AI, Cox NJ.

Science. 2009 Jul 10;325(5937):197-201. doi: 10.1126/science.1176225. Epub 2009 May 22.

18.
19.

Experimental infection of pigs with the human 1918 pandemic influenza virus.

Weingartl HM, Albrecht RA, Lager KM, Babiuk S, Marszal P, Neufeld J, Embury-Hyatt C, Lekcharoensuk P, Tumpey TM, García-Sastre A, Richt JA.

J Virol. 2009 May;83(9):4287-96. doi: 10.1128/JVI.02399-08. Epub 2009 Feb 18.

20.

High prevalence of amantadine resistance among circulating European porcine influenza A viruses.

Krumbholz A, Schmidtke M, Bergmann S, Motzke S, Bauer K, Stech J, Dürrwald R, Wutzler P, Zell R.

J Gen Virol. 2009 Apr;90(Pt 4):900-8. doi: 10.1099/vir.2008.007260-0. Epub 2009 Feb 17.

PMID:
19223487
Items per page

Supplemental Content

Write to the Help Desk